2025 annual financial data
Taysha Gene Therapies 2025 Operating margin
Taysha Gene Therapies 2025 operating margin with verified reported values.
Direct answer
Operating margin was -1,130.65%.
Operating income was -110,498,000 USD and net income was -108,995,000 USD.
Operating cash flow was -93,090,000 USD.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,773,000 USD
- Operating income
- -110,498,000 USD
- Net income
- -108,995,000 USD
- Operating cash flow
- -93,090,000 USD